Skip to content
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
CHEN LAB
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
CHEN LAB
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
CHEN LAB
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
Alagpulinsa Lab
CHEN LAB
Dai Lab
Gelfand Lab
Mukerji Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
Diversity
NEWS
DONATE
VIC Ukraine
VIC NEWS
NEWS HIGHLIGHTS
From the blog
David Verrill Goodbye Event
June 2, 2022
EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever
June 2, 2022
COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic
May 12, 2022
A new platform for immunotherapeutic RNA delivery to cancer cells
May 2, 2022
Immune cell ‘Soldier’ identified as potential target for immunotherapy
May 2, 2022
Dual-drug treatment offers promise for advanced melanoma patients
April 12, 2022
Novel drug combination may boost chemoimmunotherapy response in bladder cancer patients
April 5, 2022
Two-pronged immunotherapy treatment tested for effectiveness against glioblastomas
April 5, 2022
Recent data published indicates great hope in a newly developed COVID-19 vaccine
March 21, 2022
Restoring p53 function with mRNA nanoparticles and immune checkpoint blockade to enhance immunotherapy
March 14, 2022
181 Nobel Laureates condemn Vladimir Putin’s unprovoked and brutal invasion of Ukraine.
March 14, 2022
Exciting research reveals new potential in investigating “hybrid immunity” against Covid-19 and evolving variant
March 2, 2022
Three pillars of pandemic preparedness to end this one while preparing for the next
February 14, 2022
Voltron Therapeutics, a Laidlaw Venture Partner, Announces Selection of Therapeutic Targets for Immuno-Oncology Program
January 31, 2022
B cells do more than just help fight infection: a new study shows that they can support tissue repair and regeneration after injury
January 31, 2022
FASEB Journal publication from VIC’s Dr. Sîrbulescu and her team.
November 22, 2021
Mark Poznansky and VIC hosted the annual Professor Dulcie V. Coleman Lecture
November 22, 2021
Clofazimine for babesiosis: preclinical data support a clinical trial
October 21, 2021
IBD Patients Like Eric Prompt More Questions About COVID-19
September 18, 2021
A Virus-Hunter’s Advice on Dealing with China’s Resistance on Covid
September 18, 2021
Summer Students at VIC
July 30, 2021
As Delta variant spreads, Americans wonder about vaccine booster
July 30, 2021
Freedom from restrictions means COVID is free to run rampant
July 28, 2021
The VIC team working with Pinpoint Science, Inc scientists to assess a new rapid point of care COVID test.
July 23, 2021
Mark Poznansky in Roxbury on Juneteenth as one of the MGB doctors helping to promote COVID vaccine confidence.
July 23, 2021
Next Generation COVID vaccines
June 21, 2021
« Prev
1
2
3
4
Next »
VICatMGH
Philanthropic support is critical to VIC’s success
DONATE
>